• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

ABE Masahiro  安倍 正博

ORCIDConnect your ORCID iD *help
… Alternative Names

安部 正博  アベ マサヒロ

安倍 正博  アベ マサヒロ

Less
Researcher Number 80263812
Other IDs
Affiliation (based on the past Project Information) *help 2018 – 2023: 徳島大学, 大学院医歯薬学研究部(医学域), 教授
2016 – 2017: 徳島大学, 大学院医歯薬学研究部(医学系), 教授
2015: 徳島大学, 大学院医歯薬学研究部, 教授
2014: 徳島大学, ヘルスバイオサイエンス研究部, 教授
2013: 徳島大学, 大学院ヘルスバイオサイエンス研究部, 准教授 … More
2011 – 2013: 徳島大学, ヘルスバイオサイエンス研究部, 准教授
2007 – 2010: The University of Tokushima, Institute of Health Biorsciences, Graduate School, Associate Professor
2006: 徳島大学, バイオヘルスサイエンス研究部, 助教授
2003 – 2005: The University of Tokushima, University Hospital, Assistant Professor, 医学部・歯学部附属病院, 講師
2003: 徳島大学, 歯学部附属病院, 講師
2002: The University of Tokushima, Univ.Hospital, Lecturer, 医学部附属病院, 講師
2001: 徳島大学, 医学部・附属病院, 講師
1999 – 2001: 徳島大学, 医学部, 講師 Less
Review Section/Research Field
Principal Investigator
Hematology / Basic Section 54010:Hematology and medical oncology-related / Hematology
Except Principal Investigator
Endocrinology / Hematology / Science and Engineering / Basic Section 57020:Oral pathobiological science-related / Basic Section 52010:General internal medicine-related / Endocrinology / Biological Sciences
Keywords
Principal Investigator
多発性骨髄腫 / 骨髄腫 / 破骨細胞 / 骨病変 / PIM2 / TAK1 / IL-6 / osteoclast / VLA-4 / RANKL … More / MIP-1 / 骨髄微小環境 / TAK-1 / Pim-2 / 骨形成 / 薬剤耐性 / 骨代謝 / 貧血 / バイオマーカー / 骨髄間質細胞 / TAK1 / 阻害薬 / 骨破壊 / osteopontin / angiogenesis / myeloma / オステオポンチン / 血管新生 / 骨髄腫細胞 / chemokine / multiple myeloma / ケモカイン / 酸性環境 / TRPV1 / 酸環境 / 骨破壊病変 / アポトーシス / 骨芽細胞 / Pimキナーゼ / 血液腫瘍学 … More
Except Principal Investigator
骨髄腫 / 破骨細胞 / 骨芽細胞 / 免疫療法 / 造血器腫瘍 / RANK ligand / Wntシグナル / 骨粗鬆症 / 老化 / 転写因子 / 細胞分化 / PP2A / 骨髄間質細胞 / 脱リン酸化 / CIP2A / TAK1 / サルコペニア / Myostatin / 炎症性サイトカイン誘導性筋障害 / 骨格筋萎縮 / 炎症性サイトカイン / TAK1阻害 / Endothelial cells / Gluencorticoid / Angiogenesis / Wnt signal / Multiple myeloma / AFosB / Interleukin-11 (IL-11) / Mechanical stress / DeltaFosB / g / 血管内皮機能 / グルココルチコイド / 血管新生 / Wnt / ΔFosB / IL-11 / 力学的負荷 / molecular targeting therapy / immnnotherapy / hematological malignancy / 分子標的治療 / 造血器鍾瘍 / immunotherary / monoclonal antibody / hematoloeical malienanc / モノクローナル抗体 / chemokine / myeloma / transcription factor / osteoclast / bone resorption / インテグリン / オステオポンチン / MIP-1 / ケモカイン / 骨吸収 / マルチスケール・マルチモダリティ画像 / 肺・大腸・肝臓に発生する悪性腫瘍の本態解明 / 3次元ミクロからマクロの病態 / 肺を中心に大腸・腎臓に発生する悪性腫瘍の本態解明 / マルチスケール・マルチモダリティ画像データベース / 腫瘍診断支援システム / 多元計算解剖モデル / 脂質 / シグナル伝達 / 遺伝子 / Pim-2 / 脂肪細胞 / インターロイキン-11 (IL-11) / マルチモダリティ画像データベース / 計算解剖モデル / がん(肺がん、肝がん、膵臓がん、大腸がん) / がん(肺がん、肝がん、膵臓がん、大腸がん) / 心血管・リンパ節疾患 / 慢性閉塞疾患(COPD) / がん(肺がん、肝がん、大腸がん) / コンピュータ支援診断システム / 計算解剖学 / アンドロゲン / interleukin-11 / 動脈硬化 / 糖尿病 / 多発性骨髄腫 / 内科 / 破骨細部 / インターロイキン-11 / AP-1 Less
  • Research Projects

    (17 results)
  • Research Products

    (184 results)
  • Co-Researchers

    (59 People)
  •  分泌蛋白の網羅解析による骨髄腫の未知の病態形成/予後因子の探索と新規治療の開発Principal Investigator

    • Principal Investigator
      安倍 正博
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      The University of Tokushima
  •  Inflammatory cytokine-induced muscle atrophy and weakness can be ameliorated by an inhibition of TGF-beta-activated kinase-1

    • Principal Investigator
      ENDO Itsuro
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52010:General internal medicine-related
    • Research Institution
      The University of Tokushima
  •  骨破壊腫瘍進展と骨病変形成における細胞内情報伝達系の恒常的活性化機構の解明と制御

    • Principal Investigator
      寺町 順平
    • Project Period (FY)
      2021 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 57020:Oral pathobiological science-related
    • Research Institution
      Okayama University
  •  The roles of the TAK1-Pim-2 pathway in drug resistance and bone destruction in multiple myeloma and development of novel agents to conquer themPrincipal Investigator

    • Principal Investigator
      ABE Masahiro
    • Project Period (FY)
      2018 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      The University of Tokushima
  •  Cancer Diagnosis and Prognosis Assistance Based on Multidisciplinary Computational Anatomy

    • Principal Investigator
      Niki Noboru
    • Project Period (FY)
      2014 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
    • Review Section
      Science and Engineering
    • Research Institution
      The University of Tokushima
  •  Mechanisms of myeloma growth in bone marrow microenvironment and development of novel therapeutic options for myelomaPrincipal Investigator

    • Principal Investigator
      ABE Masahiro
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      The University of Tokushima
  •  Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders

    • Principal Investigator
      MATSUMOTO Toshio
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Endocrinology
    • Research Institution
      The University of Tokushima
  •  Mechanisms of bone destruction and drug resistance in myeloma: a novel therapeutic strategy targeting a myeloma-bone marrow interactionPrincipal Investigator

    • Principal Investigator
      ABE Masahiro
    • Project Period (FY)
      2011 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      The University of Tokushima
  •  Computer-Aided Diagnosis Based on Computational Anatomical Models

    • Principal Investigator
      NIKI Noboru
    • Project Period (FY)
      2009 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
    • Review Section
      Science and Engineering
    • Research Institution
      The University of Tokushima
  •  Relationships among skeletal, adipose and vasclar regulatory system, and elucidation of pathogensis caused by disturbances of these systems

    • Principal Investigator
      MATSUMOTO Toshio
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      Endocrinology
    • Research Institution
      The University of Tokushima
  •  Molecular mechanic sum of the regulation and dies regulation of bone homeostasis and Development of therapeutic approaches

    • Principal Investigator
      MATSUMOTO Toshio
    • Project Period (FY)
      2005 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      Endocrinology
    • Research Institution
      The University of Tokushima
  •  Identification and clinical application of osteoclast-derived growth factors for myelomaPrincipal Investigator

    • Principal Investigator
      ABE Masahiro
    • Project Period (FY)
      2003 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      The University of Tokushima
  •  Elucidation of signal transduction pathway via HM1.24 and application toward the treatment of hematological malignancies

    • Principal Investigator
      OZAKI Shuji
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      The University of Tokushima
  •  Development of immunotherapy targeting neoplastic lymphocyte-specific antigen (2D7) against hematological malignancies

    • Principal Investigator
      MATSUMOTO Toshio
    • Project Period (FY)
      2001 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Hematology
    • Research Institution
      The University of Tokushima
  •  Roles for MIP-1α and β in the development of osteolytic lesions in multiple myelomaPrincipal Investigator

    • Principal Investigator
      ABE Masahiro
    • Project Period (FY)
      2001 – 2002
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      The University OF Tokushima
  •  骨格系の制御に関わる転写因子と骨粗鬆症におけるその異常

    • Principal Investigator
      MATSUMOTO Toshio
    • Project Period (FY)
      2000 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      The University of Tokushima
  •  Mechanism of signal transduction that regulates osteoclast differentiation and its abnormalities in bone distructive diseases

    • Principal Investigator
      MATSUMOTO Toshio
    • Project Period (FY)
      1999 – 2001
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Endocrinology
    • Research Institution
      The University of Tokushima

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2004 2002 Other

All Journal Article Presentation Book Patent Other

  • [Book] 多発性骨髄腫update2023

    • Author(s)
      寺町順平, 安倍正博
    • Total Pages
      652
    • Publisher
      日本臨牀社
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Book] 骨髄腫Updating第2巻2013

    • Author(s)
      安倍正博
    • Total Pages
      303
    • Publisher
      医薬ジャーナル社
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Book] 骨髄腫Updating第1巻2012

    • Author(s)
      安倍正博
    • Total Pages
      235
    • Publisher
      医薬ジャーナル社
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors2024

    • Author(s)
      Sogabe K、Nakamura S、Higa Y、Miki H、Oda A、Maruhashi T、Sumitani R、Oura M、Takahashi M、Nakamura M、Maeda Y、Hara T、Yamagami H、Fujii S、Kagawa K、Ozaki S、Kurahashi K、Endo I、Aihara K、Nakaue E、Hiasa M、Teramachi J、Harada T、Abe M
    • Journal Title

      International Journal of Hematology

      Volume: 119 Issue: 3 Pages: 303-315

    • DOI

      10.1007/s12185-023-03705-9

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-22K08455, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K27791
  • [Journal Article] Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents2023

    • Author(s)
      Teramachi Jumpei、Miki Hirokazu、Nakamura Shingen、Hiasa Masahiro、Harada Takeshi、Abe Masahiro
    • Journal Title

      Journal of Bone and Mineral Metabolism

      Volume: - Issue: 3 Pages: 388-403

    • DOI

      10.1007/s00774-023-01403-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08455, KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-23K21485
  • [Journal Article] Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors2023

    • Author(s)
      Nakaue Emiko、Teramachi Jumpei、Tenshin Hirofumi、Hiasa Masahiro、Harada Takeshi、Oda Asuka、Inoue Yusuke、Shimizu So、Higa Yoshiki、Sogabe Kimiko、Oura Masahiro、Hara Tomoyo、Sumitani Ryohei、Maruhashi Tomoko、Yamagami Hiroki、Endo Itsuro、Tanaka Eiji、Abe Masahiro
    • Journal Title

      International Journal of Hematology

      Volume: - Issue: 1 Pages: 88-98

    • DOI

      10.1007/s12185-023-03601-2

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08455, KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-23K15975, KAKENHI-PROJECT-23K19694, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K27791
  • [Journal Article] Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma2023

    • Author(s)
      Oura M、Harada T、Oda A、Teramachi J、Nakayama A、Sumitani R、Inoue Y、Maeda Y、Sogabe K、Maruhashi T、Takahashi M、Fujii S、Nakamura S、Miki H、Nakamura M、Hara T、Yamagami H、Kurahashi K、Endo I、Hasegawa H、Fujiwara H、Abe M
    • Journal Title

      eJHaem

      Volume: 4 Issue: 3 Pages: 667-678

    • DOI

      10.1002/jha2.758

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K24233, KAKENHI-PROJECT-23K27455
  • [Journal Article] The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf22023

    • Author(s)
      Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M
    • Journal Title

      Antioxidants

      Volume: 12 Issue: 1 Pages: 133-133

    • DOI

      10.3390/antiox12010133

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08455, KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-22H03104, KAKENHI-PROJECT-21K21016, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K15975, KAKENHI-PROJECT-23K16151, KAKENHI-PROJECT-23K19694
  • [Journal Article] Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase2023

    • Author(s)
      Harada Takeshi、Ohguchi Hiroto、Oda Asuka、Nakao Michiyasu、Teramachi Jumpei、Hiasa Masahiro、Sumitani Ryohei、Oura Masahiro、Sogabe Kimiko、Maruhashi Tomoko、Takahashi Mamiko、Fujii Shiro、Nakamura Shingen、Miki Hirokazu、Kagawa Kumiko、Ozaki Shuji、Sano Shigeki、Hideshima Teru、Abe Masahiro
    • Journal Title

      Blood Advances

      Volume: 7 Issue: 6 Pages: 1019-1032

    • DOI

      10.1182/bloodadvances.2022007155

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-20K08734, KAKENHI-PROJECT-23K21485
  • [Journal Article] Sarcopenia phenotype and impaired muscle function in male mice with fast-twitch muscle-specific knockout of the androgen receptor2023

    • Author(s)
      Hosoi Tatsuya、Yakabe Mitsutaka、Sasakawa Hiroko、Sasako Takayoshi、Ueki Kohjiro、Kato Shigeaki、Tokuoka Suzumi M.、Oda Yoshiya、Abe Masahiro、Matsumoto Toshio、Akishita Masahiro、Ogawa Sumito
    • Journal Title

      Proceedings of the National Academy of Sciences

      Volume: 120 Issue: 4

    • DOI

      10.1073/pnas.2218032120

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22K07465, KAKENHI-PROJECT-22H03104
  • [Journal Article] A Genome-Wide Association Study Predicts the Onset of Dysgeusia Due to Anti-cancer Drug Treatment2022

    • Author(s)
      Takei M, Okada N, Nakamura S, Kagawa K, Fujii S, Miki H, Ishizawa K, Abe M, Sato Y.
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 45 Issue: 1 Pages: 114-117

    • DOI

      10.1248/bpb.b21-00745

    • NAID

      130008139002

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2022-01-01
    • Language
      English
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-21H02646, KAKENHI-PROJECT-21K16244
  • [Journal Article] Mechanical unloading aggravates bone destruction and tumor expansion in myeloma2022

    • Author(s)
      Tanimoto K, Hiasa M, Tenshin H, Teramachi J, Oda A, Harada T, Higa Y, Sogabe K, Oura M, Sumitani R, Hara T, Endo I, Matsumoto T, Tanaka E, Abe M
    • Journal Title

      Haematologica

      Volume: 107 Issue: 3 Pages: 744-749

    • DOI

      10.3324/haematol.2021.278295

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-20K18784, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-21K21016
  • [Journal Article] Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index2022

    • Author(s)
      Mitsui Y, Kuroda A, Ishizu M, Mori H, Kurahashi K, Kondo T, Yoshida S, Akehi Y, Aihara KI, Endo I, Abe M, Matsuhisa M
    • Journal Title

      J Diabetes Investig

      Volume: 13 Issue: 2 Pages: 292-298

    • DOI

      10.1111/jdi.13547

    • NAID

      120007181368

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy2022

    • Author(s)
      Yamada H、Ohmori R、Okada N、Nakamura S、Kagawa K、Fujii S、Miki H、Ishizawa K、Abe M、Sato Y
    • Journal Title

      The Pharmacogenomics Journal

      Volume: 22 Issue: 4 Pages: 241-246

    • DOI

      10.1038/s41397-022-00282-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21H02646, KAKENHI-PROJECT-22H03104
  • [Journal Article] TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression2022

    • Author(s)
      Tenshin H, Teramachi J, Ashtar M, Hiasa M, Inoue Y, Oda A, Tanimoto K, Shimizu S, Higa Yi, Harada T, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Sebe M, Tsutsumi R, Sakaue H, Endo I, Matsumoto T, Tanaka E, Abe M
    • Journal Title

      Clinical & Translational Immunology

      Volume: 11 Issue: 1

    • DOI

      10.1002/cti2.1371

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-20K18784, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-19H04055, KAKENHI-PROJECT-22K19626, KAKENHI-PROJECT-23K21485, KAKENHI-PROJECT-23K24792
  • [Journal Article] The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease2022

    • Author(s)
      Hirokazu Miki,Shingen Nakamura,Masahiro Oura,Masafumi Nakamura,Ryohei Sumitani,Kimiko Sogabe,Mamiko Takahashi,Tomoko Maruhashi,Takeshi Harada,Shiro Fujii,Hirofumi Hamano,Masateru Kondo,Naoto Okada,Itsuro Endo,Masahiro Abe
    • Journal Title

      eJHaem

      Volume: - Issue: 2 Pages: 480-483

    • DOI

      10.1002/jha2.402

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K08712, KAKENHI-PROJECT-21K16244, KAKENHI-PROJECT-22H03104
  • [Journal Article] Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis2022

    • Author(s)
      Dong Bingzi、Hiasa Masahiro、Higa Yoshiki、Ohnishi Yukiyo、Endo Itsuro、Kondo Takeshi、Takashi Yuichi、Tsoumpra Maria、Kainuma Risa、Sawatsubashi Shun、Kiyonari Hiroshi、Shioi Go、Sakaue Hiroshi、Nakashima Tomoki、Kato Shigeaki、Abe Masahiro、Fukumoto Seiji、Matsumoto Toshio
    • Journal Title

      Nature Communications

      Volume: 13 Issue: 1 Pages: 7194-7194

    • DOI

      10.1038/s41467-022-34869-3

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20H00551, KAKENHI-PROJECT-22H03104, KAKENHI-PROJECT-21K19554, KAKENHI-PROJECT-23K24792
  • [Journal Article] Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span2021

    • Author(s)
      Takashi Y, Sawatsubashi S, Endo I, Ohnishi Y, Abe M, Matsuhisa M, Kawanami D, Matsumoto T, Fukumoto S
    • Journal Title

      Biochem Biophys Rep

      Volume: 27 Pages: 101-107

    • NAID

      120007146085

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes.2021

    • Author(s)
      Hara T, Uemoto R, Sekine A, Mitsui Y, Masuda S, Kurahashi K, Yoshida S, Otoda T, Yuasa T, Kuroda A, Ikeda Y, Endo I, Honda S, Yoshimoto K, Kondo A, Tamaki T, Matsumoto T, Matsuhisa M, Abe M, Aihara KI
    • Journal Title

      J Diabetes Investig

      Volume: 12 Pages: 2172-2182

    • NAID

      120007182107

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations2021

    • Author(s)
      Brown JE, Wood SL, Confavreux C, Abe M, Weilbaecher K, Hadji P, Johnson RW, Rhoades JA, Edwards CM, Croucher PI, Juarez P, El Badri S, Ariaspinilla G, D'Oronzo S, Guise TA, Van Poznak C
    • Journal Title

      J Bone Oncol

      Volume: 29 Pages: 100375-100375

    • DOI

      10.1016/j.jbo.2021.100375

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] Pathogenesis and treatment of multiple myeloma bone disease2021

    • Author(s)
      2. Hiasa M, Harada T, Tanaka E, Abe M
    • Journal Title

      Jpn Dent Sci Rev

      Volume: 57 Pages: 164-173

    • DOI

      10.1016/j.jdsr.2021.08.006

    • NAID

      210000172895

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719
  • [Journal Article] Myeloma-Bone Interaction: A Vicious Cycle via TAK1-PIM2 Signaling2021

    • Author(s)
      1. Harada T, Hiasa M, Teramachi J, Abe M
    • Journal Title

      Cancers

      Volume: 13 Issue: 17 Pages: 4441-4441

    • DOI

      10.3390/cancers13174441

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-20K17402, KAKENHI-PROJECT-17KK0169
  • [Journal Article] Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma.2020

    • Author(s)
      Keiichiro Watanabe、Ariunzaya Bat-Erdene、Hirofumi Tenshin、Qu Cui、Jumpei Teramachi、Masahiro Hiasa、Asuka Oda、Takeshi Harada、Hirokazu Miki、Kimiko Sogabe、Masahiro Oura、Ryohei Sumitani、Yukari Mitsui、Itsuro Endo、Eiji Tanaka、Makoto Kawatani、Hiroyuki Osada、Toshio Matsumoto、Masahiro Abe
    • Journal Title

      Haematologica

      Volume: 106 Issue: 4 Pages: 1172-1177

    • DOI

      10.3324/haematol.2019.244418

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K05744, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-17KK0169, KAKENHI-PLANNED-17H06412, KAKENHI-PROJECT-17H05104, KAKENHI-PROJECT-20K18784
  • [Journal Article] The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.2020

    • Author(s)
      1. Ashtar M, Tenshin H, Teramachi J, Bat-Erdene A, Hiasa M, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Nakamura S, Fujii S, Sumitani R, Miki H, Udaka K, Takahashi M, Kagawa K, Endo I, Tanaka E, Matsumoto T, Abe M.
    • Journal Title

      Cancers (Basel)

      Volume: 12 Issue: 4 Pages: 929-929

    • DOI

      10.3390/cancers12040929

    • NAID

      120006894611

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K17858, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-20K18784, KAKENHI-PROJECT-17H05104
  • [Journal Article] Clinical utility of target capture‐based panel sequencing in hematological malignancies: A multicenter feasibility study2020

    • Author(s)
      Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Abe M.
    • Journal Title

      Cancer Science

      Volume: 111 Issue: 9 Pages: 3367-3378

    • DOI

      10.1111/cas.14552

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08723, KAKENHI-PROJECT-20K08759, KAKENHI-PROJECT-19H05656
  • [Journal Article] TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.2020

    • Author(s)
      2. Teramachi J, Tenshin H, Hiasa M, Oda A, Bat-Erdene A, Harada T, Nakamura S, Ashtar M, Shimizu S, Iwasa M, Sogabe K, Oura M, Fujii S, Kagawa K, Miki H, Endo I, Haneji T, Matsumoto T, Abe M.
    • Journal Title

      Haematologica

      Volume: haematol.2019 Issue: 5 Pages: 1401-1413

    • DOI

      10.3324/haematol.2019.234476

    • NAID

      120007180361

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K17858, KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-17H05104
  • [Journal Article] Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancer2020

    • Author(s)
      Sogawa Yuka、Fukui Makoto、Nakamura Shingen、Sogabe Kimiko、Sumitani Ryohei、Yoshioka Masami、Abe Masahiro、Hinode Daisuke
    • Journal Title

      International Journal of Hematology

      Volume: 112 Issue: 6 Pages: 851-859

    • DOI

      10.1007/s12185-020-02975-x

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K10432
  • [Journal Article] Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study2019

    • Author(s)
      Okada N, Chuma M, Azuma M, Nakamura S, Miki H, Hamano H, Goda M, Takechi K, Zamami Y, Abe M, Ishizawa K
    • Journal Title

      Eur J Clin Pharmacol

      Volume: 75 Issue: 12 Pages: 1695-1704

    • DOI

      10.1007/s00228-019-02756-4

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K16448
  • [Journal Article] Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma.2019

    • Author(s)
      Miki H, Nakamura S, Oura M, Hamano H, Ikuta K, Okada N, Okamoto Y, Sogabe K, Takahashi M, Iwasa M, Udaka K, Harada T, Kurahashi K, Fujii S, Yoshida S, Kagawa K, Endo I, Aihara KI, Abe M.
    • Journal Title

      British Journal of Haematology

      Volume: in press Issue: 2 Pages: 355-358

    • DOI

      10.1111/bjh.15837

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K09956, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K17858
  • [Journal Article] JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma.2019

    • Author(s)
      Iida S, Shimazaki C, Abe M, Nakaseko C
    • Journal Title

      Int J Hematol

      Volume: 109 Issue: 6 Pages: 633-640

    • DOI

      10.1007/s12185-019-02640-y

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ2019

    • Author(s)
      Iwasa M, Harada T, Oda A, Bat-Erdene A, Teramachi J, TenshinT, Ashtar M, Oura M, Sogabe K, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S and Abe M
    • Journal Title

      Oncotarget

      Volume: 10 Pages: 1903-1917

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM)2019

    • Author(s)
      Iida S, Ishida T, Murakami H, Ozaki S, Abe M, Hata H, Shimazaki C
    • Journal Title

      Int J Hematol

      Volume: 109 Issue: 5 Pages: 509-538

    • DOI

      10.1007/s12185-019-02636-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Journal Article] Polyclonal immunoglobulin recovery after autologous stem cell transplantation is an independent prognostic factor for survival outcome in patients with multiple myeloma2019

    • Author(s)
      Ozaki S, Harada T, Yagi H, Sekimoto E, Shibata H, Shigekiyo T, Fujii S, Nakamura S, Miki H, Kagawa K, Abe M
    • Journal Title

      Cancers

      Volume: 12 Issue: 1 Pages: 12-12

    • DOI

      10.3390/cancers12010012

    • NAID

      120006894614

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K17858
  • [Journal Article] Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA2018

    • Author(s)
      Bat-Erdene Ariunzaya、Nakamura Shingen、Oda Asuka、Iwasa Masami、Teramachi Jumpei、Ashtar Mohannad、Harada Takeshi、Miki Hirokazu、Tenshin Hirofumi、Hiasa Masahiro、Fujii Shiro、Sogabe Kimiko、Oura Masahiro、Udaka Kengo、Kagawa Kumiko、Yoshida Sumiko、Aihara Ken-ichi、Kurahashi Kiyoe、Endo Itsuro、Abe Masahiro
    • Journal Title

      British Journal of Haematology

      Volume: 印刷中 Issue: 5 Pages: 969-974

    • DOI

      10.1111/bjh.15673

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-17H05104, KAKENHI-PROJECT-19K17858, KAKENHI-PROJECT-18K16118
  • [Journal Article] Expansion of Th1-like Vγ9Vδ2T cells by new generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.2017

    • Author(s)
      2. Harada T, Miki H, Cui Q, Oda A, Amachi R, Teramachi J, Bat-Erdene A, Sogabe K, Iwasa M, Fujii S, Nakamura S, Kagawa K, Yoshida S, Endo I, Aihara K, Ozaki S, Matsumoto T, Abe M.
    • Journal Title

      Leukemia

      Volume: 31 Issue: 1 Pages: 258-262

    • DOI

      10.1038/leu.2016.273

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26461422, KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-16H05327
  • [Journal Article] The Japan Lung Cancer Society-Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer2017

    • Author(s)
      Tomoko Itazawa, Yukihisa Tamaki, Takafumi Komiyama, Yasumasa Nishimura, Yuko Nakayama, Hiroyuki Ito, Yasuhide Ohde, Masahiko Kusumoto, Shuji Sakai, Kenji Suzuki, Hirokazu Watanabe, Hisao Asamura
    • Journal Title

      Journal of Radiation Research

      Volume: 58 Issue: 1 Pages: 86-105

    • DOI

      10.1093/jrr/rrw076

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-16K10387, KAKENHI-PLANNED-26108007
  • [Journal Article] Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma2017

    • Author(s)
      K.Kajiura, K.Masuda, T.Naruto, T.Kohmoto, M.Watanabe, M.Tsuboi, H.Takizawa, K.Kondo, A.Tangoku, I.Imoto
    • Journal Title

      Oncotarget

      Volume: 8 Issue: 2 Pages: 2890-2905

    • DOI

      10.18632/oncotarget.13761

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PLANNED-26108007, KAKENHI-PROJECT-26293304, KAKENHI-PROJECT-15K08949, KAKENHI-PROJECT-16K15618
  • [Journal Article] Susceptibility to bendamustine considerably varies among myeloma cells, but is enhanced in acidic conditions2016

    • Author(s)
      Nakamura S , Miki H, Oda A, Amachi R, Teramachi J, Sogabe K, Fujino H, Maruhashi T, Fujii S, Kagawa K , Abe M.
    • Journal Title

      International Journal of Myeloma

      Volume: 6 Pages: 7-11

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Journal Article] Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors2016

    • Author(s)
      Bat-Erdene A, Miki H, Oda A, Nakamura S, Teramachi J, Amachi R, Tenshin H, Hiasa M, Iwasa M, Harada T, Fujii S, Sogabe K, Kagawa K, Yoshida S, Endo I, Aihara K, Abe M.
    • Journal Title

      Oncotarget

      Volume: 7 Issue: 48 Pages: 79064-79075

    • DOI

      10.18632/oncotarget.12594

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H07018, KAKENHI-PROJECT-26461422, KAKENHI-PROJECT-16K11504
  • [Journal Article] A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.2016

    • Author(s)
      Amachi R, Hiasa M, Teramachi J, Harada T, Oda A, Nakamura S, Hanson D, Watanabe K, Fujii S, Miki H, Kagawa K, Iwasa M, Endo I, Kondo T, Yoshida S, Aihara KI, Kurahashi K, Kuroda Y, Horikawa H, Tanaka E, Matsumoto T, Abe M
    • Journal Title

      Oncotarget

      Volume: 7 Issue: 43 Pages: 70447-70461

    • DOI

      10.18632/oncotarget.11927

    • NAID

      120006576954

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16H05327, KAKENHI-PROJECT-16H07018, KAKENHI-PROJECT-26461422, KAKENHI-PROJECT-16K11504
  • [Journal Article] Cavity wall thickness in solitary cavitary lung adenocarcinomas is a prognostic indicator2016

    • Author(s)
      Y.Watanabe, M.Kusumoto, A.Yoshida, K.Shiraishi, K.Suzuki, S.Watanabe, K.Tsuta.
    • Journal Title

      The Annals of Thoracic Surgery

      Volume: 102 Issue: 6 Pages: 1863-1871

    • DOI

      10.1016/j.athoracsur.2016.03.121

    • Peer Reviewed
    • Data Source
      KAKENHI-PLANNED-26108007
  • [Journal Article] Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).2015

    • Author(s)
      Dong B, Endo I, Ohnishi Y, Kondo T, Hasegawa T, Amizuka N, Kiyonari H, Shioi G, Abe M, Fukumoto S, Matsumoto T.
    • Journal Title

      J Bone Miner Res

      Volume: 30 Pages: 1980-1993

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma2015

    • Author(s)
      Hiasa M, Jumpei T, Oda A, Amachi R, Harada T, Nakamura S, Miki H, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M
    • Journal Title

      Leukemia

      Volume: 29 Pages: 207-217

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.2015

    • Author(s)
      Hiasa M, Teramachi J, Oda A, Amachi R, Harada T, Nakamura S, Miki H, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M.
    • Journal Title

      Leukemia

      Volume: 29 Pages: 207-217

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death2015

    • Author(s)
      Miki H, Nakamura S, Oda A, Amachi R, Watanabe K, Hanson D, Teramachi J, Hiasa M, Yagi H, Sogabe K, Takahashi M, Maruhashi T, Udaka K, Harada T, Fujii S, Nakano A, Kagawa K, Ri M, Iida S, Ozaki S, Matsumoto T, Abe M
    • Journal Title

      International Journal of Myeloma

      Volume: 5 Pages: 1-7

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Journal Article] Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.2015

    • Author(s)
      Hanson DJ, Nakamura S, Amachi R, Hiasa M, Oda A, Tsuji D, Itoh K, Harada T, Horikawa K, Teramachi J, Miki H, Matsumoto T, Abe M.
    • Journal Title

      Oncotarget

      Volume: 6 Pages: 33568-33586

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation2015

    • Author(s)
      6. Hanson DJ, Nakamura S, Amachi R, Hiasa M, Oda A, Tsuji D, Itoh K, Harada T, Horikawa K, Teramachi J, Miki H, Matsumoto T, Abe M.
    • Journal Title

      Oncotarget

      Volume: 6 Issue: 32 Pages: 33568-33586

    • DOI

      10.18632/oncotarget.5598

    • Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26461422, KAKENHI-PROJECT-15K14491, KAKENHI-PLANNED-23115003, KAKENHI-PROJECT-25460389, KAKENHI-PROJECT-25462859
  • [Journal Article] Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release.2014

    • Author(s)
      Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Sakamoto W, Yogo T, Ishimura K
    • Journal Title

      Theranostics

      Volume: 4 Pages: 834-844

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma2014

    • Author(s)
      Hiasa M, Jumpei T, Oda A, Amachi R, Harada T, Nakamura S, Miki S, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M
    • Journal Title

      Leukemia

      Volume: (Epub ahead of print)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Bench work for the targeted therapy to the microenvironment of myeloma bone disease.2014

    • Author(s)
      Abe M
    • Journal Title

      Clin Lymphoma Myeloma Leuk

      Volume: 14 Issue: 1 Pages: 8-9

    • DOI

      10.1016/j.clml.2013.12.006

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Defining and targeting myeloma stem cell-like cells.2014

    • Author(s)
      Abe M, Harada T, Matsumoto T
    • Journal Title

      Stem Cells

      Volume: 32 Pages: 1067-1073

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Risk factors for early-onset peripheral neuropathy caused by vincristine in patients with a first administration of R-CHOP or R-CHOP-like chemotherapy2014

    • Author(s)
      Okada N, Hanafusa T, Sakurada T, Kawazoe K, Teraoka K, Kujime T, Abe M, Shinohara Y, Minakuchi K
    • Journal Title

      J Clin Med Res

      Volume: 6 Pages: 252-260

    • DOI

      10.14740/jocmr1856w

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Journal Article] Defining and targeting myeloma stem cell-like cells2014

    • Author(s)
      Abe M, Harada T, Matsumoto T
    • Journal Title

      Stem Cells

      Volume: 32 Issue: 5 Pages: 1067-1073

    • DOI

      10.1002/stem.1643

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Fracture Risk Reduction with Denosumab in Japanese Postmenopausal Women and Men with Osteoporosis: Denosumab fracture Intervention RandomizEd placebo Controlled Trial (DIRECT).2014

    • Author(s)
      Nakamura T, Matsumoto T, Sugimoto T, Hosoi T, Miki T, Gorai I, Yoshikawa H, Tanaka Y, Tanaka S, Sone T, Nakano T, Ito M, Matsui S, Yoneda T, Takami H, Watanabe K, Osakabe T, Shiraki M, Fukunaga M
    • Journal Title

      J Clin Endocrinol Metab

      Volume: 99 Pages: 2599-2607

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.2014

    • Author(s)
      Hiasa M, Jumpei T, Oda A, Amachi R, Harada T, Nakamura S, Miki S, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M.
    • Journal Title

      Leukemia

      Volume: in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Concise review: defining and targeting myeloma stem cell-like cells.2014

    • Author(s)
      Abe M, Harada T, Matsumoto T
    • Journal Title

      Stem cells (Dayton, Ohio)

      Volume: 32 Pages: 1067-1073

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.2013

    • Author(s)
      Harada T, Ozaki S, Oda A, Tsuji D, Ikegame A, Iwasa M, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Kuroda Y, Kawai S, Itoh K, Yamada-Okabe H, Matsumoto T, Abe M.
    • Journal Title

      PLoS One

      Volume: 8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma.2013

    • Author(s)
      Harada T, Ozaki S, Oda A, Fujii S, Nakamura S, Miki H, Kagawa K, Takeuchi K, Matsumoto T, Abe M.
    • Journal Title

      Int J Hematol

      Volume: 97 Issue: 6 Pages: 743-748

    • DOI

      10.1007/s12185-013-1321-0

    • NAID

      10031183730

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-25860789
  • [Journal Article] Microenvironment for myeloma growth and drug resistance.2013

    • Author(s)
      Abe M
    • Journal Title

      International Journal of Myeloma

      Volume: 3 Pages: 2-11

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Identification of the risk factors associated with hypocalcemia induced by denosumab.2013

    • Author(s)
      Okada N, Kawazoe K, Teraoka K, Kujime T, Abe M, Shinohara Y, Minakuchi K.
    • Journal Title

      Biol Pharm Bull.

      Volume: 36 Pages: 1622-1626

    • NAID

      130003361547

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors2013

    • Author(s)
      T. Harada, S. Ozaki, A. Oda, D. Tsuji, A. Ikegame, M. Iwasa, K. Udaka, S. Fujii, S. Nakamura, H. Miki, K. Kagawa, Y. Kuroda, S. Kawai, K. Itoh, H. Yamada-Okabe, T. Matsumoto, M. Abe
    • Journal Title

      PLoS One

      Volume: vol.26; 8(12) Issue: 12 Pages: e83905-e83905

    • DOI

      10.1371/journal.pone.0083905

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23390026, KAKENHI-PROJECT-23390140, KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-24659262, KAKENHI-PUBLICLY-25110722, KAKENHI-PROJECT-25460389
  • [Journal Article] Microenvironment for myeloma growth and drug resistance2013

    • Author(s)
      Abe M
    • Journal Title

      International Journal of Myeloma

      Volume: 3 Pages: 2-11

    • URL

      http://www.jsm.gr.jp/journal.html

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.2013

    • Author(s)
      Nakamura S, Miki H, Kido S, Nakano A, Hiasa M, Oda A, Amou H, Watanabe K, Harada T, Fujii S, Takeuchi K, Kagawa K, Ozaki S, Matsumoto T, Abe M.
    • Journal Title

      Int J Hematol.

      Volume: 98 Pages: 66-73

    • NAID

      10031189598

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients.2013

    • Author(s)
      Watanabe T, Mitsuhashi M, Sagawa M, Ri M, Suzuki K, Abe M, Ohmachi K, Nakagawa Y, Nakamura S, Chosa M, Iida S, and Kizaki M.
    • Journal Title

      Blood Cancer Journal

      Volume: 3 Issue: 10 Pages: e150-e150

    • DOI

      10.1038/bcj.2013.47

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-24591409
  • [Journal Article] Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: A pilot study.2013

    • Author(s)
      Kato S, Endo I, Fujimura M, Kuriwaka-Kido R, Fujinaka Y, Aihara K, Iwase T, Inoue D, Akaike M, Abe M, Matsumoto T.
    • Journal Title

      Atherosclerosis

      Volume: 229 Pages: 182-185

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma.2013

    • Author(s)
      Harada T, Ozaki S, Oda A, Fujii S, Nakamura S, Miki H, Kagawa K, Takeuchi K, Matsumoto T, Abe M.
    • Journal Title

      Int J Hematol

      Volume: 97(6) Pages: 743-748

    • NAID

      10031183730

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Journal Article] Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.2013

    • Author(s)
      Nakamura S, Miki H, Kido S, Nakano A, Hiasa M, Oda A, Amou H, Watanabe K, Harada T, Fujii S, Takeuchi K, Kagawa K, Ozaki S, Matsumoto T, Abe M.
    • Journal Title

      Int J Hematol

      Volume: 98 Issue: 1 Pages: 66-73

    • DOI

      10.1007/s12185-013-1367-z

    • NAID

      10031189598

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-24790847
  • [Journal Article] Gold nanoparticle cluster-plasmon-enhanced fluorescent silica core-shell nanoparticles for X-ray computed tomography-fluorescence dual-mode imaging of tumors.2013

    • Author(s)
      Hayashi K, Nakamura M, Miki H, Ozaki S, Abe M, Matsumoto T, Ishimura K.
    • Journal Title

      Chem Commun

      Volume: 49 Issue: 46 Pages: 5334-5336

    • DOI

      10.1039/c3cc41876f

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-24760551
  • [Journal Article] Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment.2013

    • Author(s)
      Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, Abe M, Matsumoto T, Ishimura K.
    • Journal Title

      Theranostics

      Volume: 3 Issue: 6 Pages: 366-376

    • DOI

      10.7150/thno.5860

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-24760551
  • [Journal Article] Autologous Peripheral Blood-Derived Mononuclear Cells Induced by Erythropoietin Improve Critical Ischemic Limbs2012

    • Author(s)
      Kanbara T
    • Journal Title

      Ann Vasc Dis

      Volume: 5 Issue: 1 Pages: 52-60

    • DOI

      10.3400/avd.oa.11.00070

    • NAID

      130004695429

    • ISSN
      1881-641X, 1881-6428
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390392, KAKENHI-PROJECT-22390159, KAKENHI-PROJECT-23591046, KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-24659392
  • [Journal Article] 多発性骨髄腫―現状と進歩 骨髄腫の骨病変:骨破壊機序と骨病変に対する標的療法2012

    • Author(s)
      安倍正博
    • Journal Title

      医学のあゆみ

      Volume: 第242巻第13号 Pages: 1068-1073

    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] TRAIL produced from multiple myeloma cell is associated with osteolytic markers2012

    • Author(s)
      Kawano Y, Ueno S, Abe M, Kikukawa Y, Yuki H, lyama K, Okuno Y, Mitsuya H, Hata H
    • Journal Title

      Oncol Rep

      Volume: 27 Issue: 2 Pages: 39-44

    • DOI

      10.1371/journal.pone.0031594

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] 骨髄腫の分子病態 造血器腫瘍学―基礎と臨床の最新研究動向―2012

    • Author(s)
      安倍正博
    • Journal Title

      日本臨床

      Volume: 70 Pages: 577-583

    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate2012

    • Author(s)
      Nakano A, Miki H, Nakamura S, Harada T, Oda A, Amou H, Fujii S, Kagawa K, Takeuchi K, Ozaki 5, Matsumoto T, Abe M
    • Journal Title

      J Bioenerg Biomembr

      Volume: 44 Issue: 1 Pages: 31-38

    • DOI

      10.1007/s10863-012-9412-9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients2012

    • Author(s)
      Hosen N, Matsuoka Y, Kishida S, Nakata J, Mizutani Y, Hasegawa K, Mugitani A, Ichihara H, Aoyama Y, Nishida S, Tsuboi A, Fujiki F, Tatsumi N, Nakajima H, Hino M, Kimura T, Yata K, Abe M, Oka Y, Oji Y, Kumanogoh A, Sugiyama H.
    • Journal Title

      Leukemia

      Volume: (in press) Issue: 9 Pages: 2135-2141

    • DOI

      10.1038/leu.2012.80

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591205, KAKENHI-PUBLICLY-23130509, KAKENHI-PROJECT-23591386, KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23790622
  • [Journal Article] Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors2012

    • Author(s)
      Ikegame A, Ozaki S, Tsuji D, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, Kagawa K, Takeuchi K, Abe M, Watanabe K, Hiasa M, Kimura N, Kikuchi Y, Sakamoto A, Habu K, Endo M, Itoh K, Yamada-Okabe H, MatsumotoT
    • Journal Title

      Leukemia

      Volume: 26 Issue: 9 Pages: 2124-2134

    • DOI

      10.1038/leu.2012.78

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790318, KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
  • [Journal Article] 骨免疫学―研究最前線 骨髄腫の骨破壊機序2012

    • Author(s)
      安倍正博
    • Journal Title

      医学のあゆみ

      Volume: 第242巻第9号 Pages: 697-702

    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL2012

    • Author(s)
      Kagawa K, Nakano A, Miki H, Oda A, Amou H, Takeuchi K, Nakamura S, Harada T, Fujii S, Yata K, Ozaki S, Matsumoto T, Abe M
    • Journal Title

      PLoS One

      Volume: 7 Issue: 11 Pages: e27222-e27222

    • DOI

      10.1371/journal.pone.0027222

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Delayed treatment with vitamin C and N-acetyl-L:-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.2011

    • Author(s)
      Nakano A, Abe M, Oda A, Amou H, Hiasa M, Nakamura S, Miki H, Harada T, Fujii S, Kagawa K, Takeuchi K, Watanabe T, Ozaki S, Matsumoto T
    • Journal Title

      Int J Hematol 93

      Pages: 727-735

    • NAID

      10029535471

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] TGF-β-related mechanisms of bone destruction in multiplemyeloma.2011

    • Author(s)
      Matsumoto T, Abe M
    • Journal Title

      Bone 48

      Pages: 129-134

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Transient inflammatory reaction during Ienalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma.2011

    • Author(s)
      Ozaki S, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, Kagawa K, Takeuchi K, Abe M, Matsumoto T
    • Journal Title

      Int J Hematol 93

      Pages: 257-259

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Targeting myeloma-osteoclast interaction with V γ 9V 6 2 T cells2011

    • Author(s)
      Cui Q, Shibata H, Oda A, Amou H, Nakano A, Yata K, Hiasa M, Watanabe K, Nakamura S, Miki H, Harada T, Fujii S, Kagawa K, Takeuchi K, Ozaki S, Matsumoto T, Abe M
    • Journal Title

      Int J Hematol

      Volume: 94 Issue: 1 Pages: 63-70

    • DOI

      10.1007/s12185-011-0885-9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
  • [Journal Article] KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts2011

    • Author(s)
      Miki H, Ozaki S, Nakamura S, Oda A, Amou H, Ikegame A, Watanabe K, Hiasa M, Cui Q, Harada T, Fujii S, Nakano A, Kagawa K, Takeuchi K, Yata K, Sakai A, Abe M, Matsumoto T
    • Journal Title

      Br J Haematol

      Volume: 155 Issue: 3 Pages: 328-339

    • DOI

      10.1111/j.1365-2141.2011.08844.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
  • [Journal Article] Delayed treatment with vitamin C and N-acetyl-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib2011

    • Author(s)
      Nakano A, Abe M, Oda A, Amou A, Hiasa M, Nakamura S, Miki H, Harada T, Fujii S, Kagawa K, Takeuchi K, Watanabe T, Ozaki S, Matsumoto T
    • Journal Title

      Int J Hematol

      Volume: 93 Issue: 6 Pages: 727-735

    • DOI

      10.1007/s12185-011-0850-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
  • [Journal Article] Activation of Peroxisome Proliferator-activated Receptor alpha in Megakaryocytes Reduces Platelet-derived Growth Factor-BB in Platelets2011

    • Author(s)
      Hashizume S, Akaike M, Azuma H, Ishikawa K, Yoshida S, Sumitomo-Ueda Y, Yagi S, Ikeda Y, Iwase T, Aihara KI, Abe M, Sata M, Matsumoto T
    • Journal Title

      J Atheroscler Thromb 18

      Pages: 138-147

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells2011

    • Author(s)
      Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K-I, Sakai A, Ozaki S, Matsumoto T, Abe M
    • Journal Title

      Leukemia in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma2011

    • Author(s)
      Abe M
    • Journal Title

      Int J Hematol

      Volume: 94 Issue: 4 Pages: 334-343

    • DOI

      10.1007/s12185-011-0949-x

    • NAID

      10030265135

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells2011

    • Author(s)
      Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, Miki H, Nakamura S, Harada T, Fujii S, Kagawa K, Endo I, Yata K, Sakai A, Ozaki S, Matsumoto T, Abe M
    • Journal Title

      Leukemia

      Volume: 25 Issue: 7 Pages: 1182-1188

    • DOI

      10.1038/leu.2011.60

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23659946
  • [Journal Article] Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agents2011

    • Author(s)
      Abe M
    • Journal Title

      Int J Hematol

      Volume: 94 Issue: 4 Pages: 307-309

    • DOI

      10.1007/s12185-011-0950-4

    • NAID

      10030264986

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Journal Article] Induction of endosomal/lysosomal pathways in differentiating osteoblasts as revealed by combined proteomic and transcriptomic analyses.2010

    • Author(s)
      Taniguchi T, Kido S, Yamauchi E, Abe M, Matsumoto T, Taniguchi H
    • Journal Title

      FEBS Lett 584

      Pages: 3969-3974

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.2010

    • Author(s)
      Takeuchi K, Abe M, Hiasa M, Oda A, Amou H, Kido S, Harada T, Tanaka O, Miki H, Nakamura S, Nakano A, Kagawa K, Yata K, Ozaki S, Matsumoto T
    • Journal Title

      PLoS ONE 5

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Size-controlled synthesis, surface functionalization, and biological applications of thiol-organosilica particles.2010

    • Author(s)
      Nakamura M, Ozaki S, Abe M, Doi H, Matsumoto T, Ishimura K
    • Journal Title

      Colloids Surf B Biointerfaces 79

      Pages: 19-26

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients.2010

    • Author(s)
      Ishiguro T, Kawai S, Habu K, Sugimoto M, Shiraiwa H, Iijima S, Ozaki S, Matsumoto T, Yamada-Okabe H
    • Journal Title

      Cancer Sci 101

      Pages: 2227-2233

    • NAID

      10027832637

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.2009

    • Author(s)
      Kitazoe K, Abe M, Hiasa M, Oda A, Amou H, Harada T, Nakano A, Takeuchi K, Hashimoto T, Ozaki S, Matsumoto T
    • Journal Title

      Int J Hematol 89

      Pages: 45-57

    • NAID

      10025159599

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein(MIP)-1α and MIP-1β production2009

    • Author(s)
      Abe M
    • Journal Title

      J Bone Miner Metab 27

      Pages: 16-23

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE).2009

    • Author(s)
      Hiasa M, Abe M, Nakano A, Oda A, Amou H, Kido S, Takeuchi K, Kagawa K, Yata K, Hashimoto T, Ozaki S, Asaoka K, Tanaka E, Moriyama K, Matsumoto T
    • Journal Title

      Blood 114

      Pages: 4517-4526

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancercells.2009

    • Author(s)
      Wang W, Nishioka Y, Ozaki S, Jalili A, Verma V, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S
    • Journal Title

      Lung Cancer 63

      Pages: 23-31

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-lalpha and MIP-1beta production.2009

    • Author(s)
      Abe, M
    • Journal Title

      J Bone Miner Metab (In press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.2009

    • Author(s)
      Wang W, Nishioka Y, Ozaki S, Jalili A, Abe S, Kakiuchi S, Kishuku M, Minakuchi K, Matsumoto T, Sone S
    • Journal Title

      Cancer Immunol Immunother 58

      Pages: 967-976

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma.2009

    • Author(s)
      Miki H, Ozaki S, Tanaka O, Lee E, Takimoto T, Watanabe H, Fujii S, Nakamura S, Kagawa K, Takeuchi K, Yata K, Abe M, Kagami S, Matsumoto T
    • Journal Title

      Int J Hematol 89

      Pages: 223-226

    • NAID

      10025160333

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-lalpha and MIP-lbeta production.2009

    • Author(s)
      Abe M, Hiura K, Ozaki S, Kido S, Matsumoto T
    • Journal Title

      J Bone Miner Metab 27

      Pages: 16-23

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] Pinl down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins.2009

    • Author(s)
      Nakano A, Koinuma D, Miyazawa K, Uchida T, Saitoh M, Kawabata M, Hanai J, Akiyama H, Abe M, Miyazono K, Matsumoto T, Imamura T
    • Journal Title

      J Biol Chem 284

      Pages: 6109-6115

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Journal Article] BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma2006

    • Author(s)
      Abe M
    • Journal Title

      Leukemia 20・7

      Pages: 1313-5

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Journal Article] Skeletal Development and Remodeling2006

    • Author(s)
      Matsumoto TAbe, M.
    • Journal Title

      Health, Diseaase, and Aging (Edited by Mone Zaidi) Bone destruction in multiple myeloma, The New York Academy of Sciences

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Journal Article] BAFF and APRIL as osteoclast-derived survival factors for myeloma cells : a rationale for TACI-Fc treatment in patients with multiple myeloma2006

    • Author(s)
      Abe, M., et. al.
    • Journal Title

      Leukemia 20

      Pages: 1313-1315

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Journal Article] BAFF and APRIL as osteoclast-derived survival factors for myeloma cells : a rationale for TACI-Fc treatment in patients with multiple myeloma2006

    • Author(s)
      Abe M
    • Journal Title

      Leukemia 20・7

      Pages: 1313-1315

    • Data Source
      KAKENHI-PROJECT-17209035
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion2004

    • Author(s)
      Abe M
    • Journal Title

      Blood 104

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-13557082
  • [Journal Article] Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation during 90-Day Bed Rest.2004

    • Author(s)
      Watanabe Y, et al.
    • Journal Title

      Journal of Bone and Mineral Research 19

      Pages: 1771-1779

    • Data Source
      KAKENHI-PROJECT-12137207
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion2004

    • Author(s)
      Abe M
    • Journal Title

      Blood 104

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570984
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion2004

    • Author(s)
      Abe M, et al.
    • Journal Title

      Blood 104

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-13557082
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion.2004

    • Author(s)
      Abe M
    • Journal Title

      Blood 104・8

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-15591010
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion.2004

    • Author(s)
      Abe M
    • Journal Title

      Blood 104-8

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-15591010
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and myeloma expansion2004

    • Author(s)
      Abe M, et al.
    • Journal Title

      Blood 104

      Pages: 2484-2491

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570984
  • [Journal Article] Osteoclasts enhance myeloma cell growth and survival via cell-cell contact : a vicious cycle between bone destruction and mveloma expansion.2004

    • Author(s)
      Abe M, et al.
    • Journal Title

      Blood 104

      Pages: 2484-2491

    • Data Source
      KAKENHI-PROJECT-12137207
  • [Journal Article] Role for macrophage inflammatory protein(MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma2002

    • Author(s)
      Abe M
    • Journal Title

      Blood 100

      Pages: 2195-2202

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570984
  • [Journal Article] Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts_by cognate interaction with activated T cells2002

    • Author(s)
      Abe M
    • Journal Title

      J Leukoc Biol 72

      Pages: 947-952

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-13557082
  • [Journal Article] Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated Tcells2002

    • Author(s)
      Abe M, et al.
    • Journal Title

      J Leukoc Biol 72

      Pages: 947-952

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-13557082
  • [Journal Article] Role for macrophage inflammatory protein(MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma2002

    • Author(s)
      Abe M
    • Journal Title

      Blood 100

      Pages: 2195-2202

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-13557082
  • [Journal Article] Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma2002

    • Author(s)
      Abe M, et al.
    • Journal Title

      Blood 100

      Pages: 2195-2202

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570984
  • [Journal Article] Role for macrophage inflammatory protein (MIP)-lalpha and MIP-lbeta in the development of osteolytic lesions in multiple myeloma2002

    • Author(s)
      Abe M, et al.
    • Journal Title

      Blood 100

      Pages: 2195-2202

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-13557082
  • [Patent] PIM2阻害剤2022

    • Inventor(s)
      寺町順平、中尾允泰、佐野茂樹、安倍正博、原田武志
    • Industrial Property Rights Holder
      徳島大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2022
    • Overseas
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Patent] HLAクラスIを認識する抗体を有効成分として含有する化学療法剤耐性癌治療剤、およびその利用2008

    • Inventor(s)
      松本 俊夫、尾崎 修治、安倍 正博
    • Industrial Property Rights Holder
      徳島大学、中外製薬
    • Filing Date
      2008-03-12
    • Description
      「研究成果報告書概要(和文)」より
    • Overseas
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Patent] エリスロポエチンを用いた虚血性疾患の治療2007

    • Inventor(s)
      松本 俊夫、北川 哲也、安倍 正博、赤池 雅史、永吉 和成、山本 要、樋口 正人
    • Industrial Property Rights Holder
      徳島大学, 中外製薬
    • Filing Date
      2007-06-07
    • Description
      「研究成果報告書概要(和文)」より
    • Overseas
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Patent] 抗HLA抗体を利用した新規医薬品2006

    • Inventor(s)
      松本俊夫, 尾崎修治, 安倍正博
    • Industrial Property Rights Holder
      徳島大学, 中外製薬
    • Filing Date
      2006-05-18
    • Acquisition Date
      2006-11-23
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Patent] 抗HLA抗体を利用した新規医薬品2006

    • Inventor(s)
      松本 俊夫、尾崎 修治、安倍 正博
    • Industrial Property Rights Holder
      徳島大学, 中外製薬
    • Filing Date
      2006-05-18
    • Description
      「研究成果報告書概要(和文)」より
    • Overseas
    • Data Source
      KAKENHI-PROJECT-17209035
  • [Presentation] 炎症性サイトカイン誘導性の筋萎縮、筋力低下はTAK1阻害により改善する2024

    • Author(s)
      遠藤 逸朗,金井麻衣, Byambasuren Ganbaatar,寺町 順平,日浅 雅博,天真 寛文,比嘉 佳基, 原倫世, 原田 武志,瀬部 真由,堤 理恵, 阪上 浩, 松本 俊夫,安倍 正博
    • Organizer
      第42回日本骨代謝学会
    • Data Source
      KAKENHI-PROJECT-21K07339
  • [Presentation] 1q増幅骨髄腫微小環境でのSLAMF7が介在する炎症ネットワーク2023

    • Author(s)
      原田武志、小田明日香、住谷龍平、井上雄介、原倫世、大浦雅博、曽我部公子、丸橋朋子、高橋真美子、藤井志朗、中村信元、三木浩和、 日浅雅博、寺町順平、安倍正博
    • Organizer
      第85回日本血液学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] TAK1阻害による炎症性サイトカイン誘導性骨格筋障害の改善2023

    • Author(s)
      金井麻衣,遠藤逸朗,大西幸代, Byambasuren Ganbaatar, 寺町順平,原倫世,瀬部真由,阪上浩,福本誠二,松本俊夫, 安倍正博
    • Organizer
      第96回日本内分泌学会学術総会
    • Data Source
      KAKENHI-PROJECT-21K07339
  • [Presentation] 骨髄腫の進展における可溶性SLAMF7による炎症惹起の役割2023

    • Author(s)
      原田武志、住谷龍平、原倫世、井上雄介、中上絵美子、天眞寛文、小田明日香、大浦雅博、曽我部公子、丸橋朋子、高橋真美子、藤井志 朗、中村信元、三木浩和、日浅雅博、寺町順平、菊池次郎、古川雄祐、安倍正博
    • Organizer
      第49回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 骨髄腫骨病変由来可溶型 SLAMF7 の骨病変微小環境に及 ぼす影響の解明2023

    • Author(s)
      原田 武志,住谷 龍平,原 倫世,天眞 寛文, 中上絵美子,井上 雄介 ,日浅 雅博 ,寺町 順平, 田中 栄二,遠藤 逸朗,安倍 正博
    • Organizer
      第41回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 骨形成誘導による骨髄腫排他的ニッチ形成の分子機序の探索2023

    • Author(s)
      金 秀河,寺町 順平,日浅 雅博,天真 寛文, 中上絵美子,田中茉里子,中川 宗純,遠藤 逸朗, 原田 武志,田中 栄二,安倍 正博
    • Organizer
      第41回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 破骨細胞は SLAMF7 を強発現し可溶性 SLAMF7 を産生する2022

    • Author(s)
      天真寛文、原田武志、井上雄介、菊池次郎、小田明日香、 住谷龍平、大浦雅博、曽我部公子、丸橋朋子、高橋真美子、藤井志朗、中村信元、 三木浩和、日浅雅博、寺町順平、鈴木敦、角川学士、峯畑健一、古川雄祐、 安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 骨転移病態の基礎:オーバービュー2022

    • Author(s)
      安倍正博
    • Organizer
      第40回日本骨代謝学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22H03104
  • [Presentation] 骨髄腫に対する抗体免疫療法への Th1 様γδ T 細胞の応用2022

    • Author(s)
      井上雄介、原田武志、天眞寛文、小田明日香、住谷龍平、大浦雅博、 曽我部公子、丸橋朋子、高橋真美子、藤井志朗、中村信元、三木浩和、日浅雅博、 寺町順平、安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 不動は骨髄腫骨病変部 DPP-4 発現増加と骨髄腫の腫瘍進展・ 髄外播種を加速させる2022

    • Author(s)
      田中茉里子,日浅雅博,谷本幸多朗, 天真寛文,清水宗,比嘉佳基, 中上絵美子,金秀河,寺町順平,原田武志, 中村信元,遠藤逸朗,田中栄二,松本俊夫, 安倍正博
    • Organizer
      第40回日本骨代謝学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] TAK1 阻害は骨髄腫の細胞間相互作用による骨破壊と薬剤耐性を改善する2022

    • Author(s)
      寺町順平、天真寛文、原田武志、日浅雅博、小田明日香、清水宗、住谷龍平、大浦雅博、曽我部公子、丸橋朋子、藤井志朗、中村信元、三木浩和、 遠藤逸朗、原田武志、安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 破骨細胞による SLAMF7 の産生と骨髄腫関連骨病変に対す る SLAMF7 標的療法の開発2022

    • Author(s)
      原田武志,天眞寛文,井上雄介,住谷龍平, 中上絵美子,寺町順平,日浅雅博,田中栄二, 松本俊夫,安倍正博
    • Organizer
      第40回日本骨代謝学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 骨髄腫骨髄微小環境の変容におけるキサンチンオキシダーゼ -ROS 経路の重要な役割2022

    • Author(s)
      比嘉佳基、日浅雅博、天真寛文、谷本幸多郎、清水宗、寺町順平、 原田武志、小田明日香、遠藤逸郎、松本俊夫、田中栄二、安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] キサンチンオキシダーゼ (XO) 阻害薬 febuxostat による脂 肪細胞分化と骨芽細胞分化の制御機構2022

    • Author(s)
      比嘉佳基、日浅雅博、天真寛文、寺町順平、 原田武志、小田明日香、遠藤逸郎、松本俊夫、田中栄二、安倍正博
    • Organizer
      第40回日本骨代謝学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] Perspective of international collaboration in the JSM2022

    • Author(s)
      安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22H03104
  • [Presentation] プロテアソーム阻害薬のパルス投与の骨代謝への影響2022

    • Author(s)
      中上絵美子、天真寛文、寺町順平、日浅雅博、原田武志、谷本幸多郎、 清水宗、比嘉佳基、住谷龍平、丸橋朋子、大浦雅博、曽我部公子、中村信元、 三木浩和、遠藤逸郎、田中栄二、安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] RNA 編集酵素 ADAR1 を標的にする 1q 増幅骨髄腫細胞に対する治療法の開発2022

    • Author(s)
      原田武志、住谷龍平、小田明日香、井上雄介、大浦雅博、 曽我部公子、丸橋朋子、高橋真美子、藤井志朗 、中村信元、三木浩和、天眞寛文、 日浅雅博、寺町順平、安倍正博
    • Organizer
      第47回日本骨髄腫学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] プロテアソーム阻害薬による骨髄腫骨病変部選択的骨形成 誘導活性の検討2022

    • Author(s)
      中上絵美子、天真寛文、日浅雅博、寺町順平、原田武志、井上雄介、谷本幸多郎、 清水宗、比嘉佳基、遠藤逸郎、田中栄二、松本俊夫、安倍正博
    • Organizer
      第40回日本骨代謝学会学術集会
    • Data Source
      KAKENHI-PROJECT-23K21485
  • [Presentation] 教育講演:多発性骨髄腫に対する治療の進歩と分子標的療法の開発2020

    • Author(s)
      安倍正博
    • Organizer
      第24回日本がん分子標的治療学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Presentation] 合同シンポジウム 6 癌と骨代謝 骨髄腫骨病変と腫瘍進展2019

    • Author(s)
      安倍 正博
    • Organizer
      第37回日本骨代謝学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Presentation] シンポジウム2 骨髄腫骨病変治療の進歩と展望2019

    • Author(s)
      安倍 正博
    • Organizer
      第44回日本骨髄腫学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Presentation] Development of novel therapeutic approaches targeting myeloma-bone marrow interplay2018

    • Author(s)
      Masahiro Abe
    • Organizer
      2018 Taiwan Society of Blood and Marrow Transplantation and the Hematology Society of Taiwan Joint Annual Congress
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Presentation] Management of patients with MGUS or multiple myeloma2018

    • Author(s)
      Masahiro Abe
    • Organizer
      The 45th Congress of the European Calcified Tissue Society
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K08329
  • [Presentation] Automated assessment of aortic and main pulmonary arterial diameters using model-based blood vessel segmentation for predicting chronic thromboembolic pulmonary hypertension in low-dose CT lung screening2018

    • Author(s)
      H.Suzuki, Y.Kawata, N.Niki, T.Sugiura, N.Tanabe, M.Kusumoto, K.Eguchi, M.Kaneko
    • Organizer
      Proc.SPIE Medical Imaging
    • Int'l Joint Research
    • Data Source
      KAKENHI-PLANNED-26108007
  • [Presentation] 多発性骨髄腫:QoLの改善に向けた治療の進歩2016

    • Author(s)
      安倍正博
    • Organizer
      第78回日本血液学会学術集会
    • Place of Presentation
      パシフィコ横浜(神奈川県・横浜市)
    • Invited
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Presentation] Quantitative analysis of thrombosis using CT images2016

    • Author(s)
      K.Fujisawa, M.Matsuhiro, H.Suzuki, Y.Kawata, N.Niki, T.Sugiura, N.Tanabe, Y.Takiguchi, K.Tatsumi
    • Organizer
      1st Asia Oceania Workshop of Pulmonary Functional Imaging combined with 8th Japanese Society of Pulmonary Functional Imaging
    • Place of Presentation
      Awaji Yumebutai International Conference Center (Awaji City, Hyogo, Japan)
    • Year and Date
      2016-01-29
    • Int'l Joint Research
    • Data Source
      KAKENHI-PLANNED-26108007
  • [Presentation] Up-regulation of the pH sensor TRPV1 in myeloma cells and their adaption to an acidic microenvironment2015

    • Author(s)
      Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Asuka Oda, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto, Masahiro Abe
    • Organizer
      American Society for Bone and Mineral Research Annual Meeting
    • Place of Presentation
      Seattle (USA)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Presentation] Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: therapeutic impact of TAK-1 inhibition.2015

    • Author(s)
      umpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe.
    • Organizer
      Annual Meeting of the American Society for Bone and Mineral Research
    • Place of Presentation
      Seattle, WA. (USA)
    • Year and Date
      2015-10-09
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] Spaceflight Bone Atrophy-Problem Solved?2015

    • Author(s)
      Adrian LeBlanc, Toshio Matsumoto, Jeffrey Jones, Jay Shapiro, Thomas Lang, Linda Shackelford, Scott M. Smith, Harlan Evans, Elisabeth Spector, Robert Ploutz-Snyder, Jean Sibonga, Joyce Keyak, Toshitaka Nakamura, Kenjiro Kohri, Hiroshi Ohshima, Gilbert Moralez.
    • Organizer
      Annual Meeting of the American Society for Bone and Mineral Research
    • Place of Presentation
      Seattle, WA. (USA)
    • Year and Date
      2015-10-09
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] RAIL is not a proapoptotic but rather anti-apoptotic mediator for osteoclasts to stimulate their differentiation and survival.2015

    • Author(s)
      Hirohfumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryota Amachi, Masahiro Hiasa, Keiishiro Watanabe, Singen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto, Masahiro Abe.
    • Organizer
      Annual Meeting of the American Society for Bone and Mineral Research
    • Place of Presentation
      Seattle, WA. (USA)
    • Year and Date
      2015-10-09
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: therapeutic impact of TAK-1 inhibition2015

    • Author(s)
      Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe
    • Organizer
      American Society for Bone and Mineral Research Annual Meeting
    • Place of Presentation
      Seattle (USA)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Presentation] 骨微小環境と骨髄腫の進展2014

    • Author(s)
      安倍正博
    • Organizer
      第32回日本骨代謝学会学術集会
    • Place of Presentation
      大阪国際会議場(大阪府大阪市)
    • Year and Date
      2014-07-24
    • Invited
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Presentation] 骨髄腫骨病変の管理:ゾレドロン酸かデノスマブか2014

    • Author(s)
      安倍正博
    • Organizer
      第76回血液学会学学術集会
    • Place of Presentation
      大阪国際会議場(大阪府大阪市)
    • Year and Date
      2014-10-31
    • Invited
    • Data Source
      KAKENHI-PROJECT-26461422
  • [Presentation] Overview of the pathophysiology of MBD and acquired genetic events: Bench work for the targeted therapy to the microenvironment of MBD2013

    • Author(s)
      M. Abe
    • Organizer
      The 14th International Myeloma Workshop
    • Place of Presentation
      京都国際会議場(京都)
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] Overview of the pathophysiology of MBD and acquired genetic events: Bench work for the targeted therapy to the microenvironmen of MBD. Session: Myeloma bone disease2013

    • Author(s)
      M Abe
    • Organizer
      The 14th International Myeloma Workshop
    • Place of Presentation
      京都国際会議場(京都府)
    • Year and Date
      2013-04-04
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] 骨髄腫骨病変と腫瘍免疫2013

    • Author(s)
      安倍正博
    • Organizer
      第34回日本炎症・再生医学会
    • Place of Presentation
      京都国際会議場(京都)
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] 骨髄腫骨病変と腫瘍免疫.シンポジウム5骨免疫と炎症性疾患2013

    • Author(s)
      安倍正博
    • Organizer
      第34回日本炎症・再生医学会
    • Place of Presentation
      京都国際会議場(京都府)
    • Year and Date
      2013-07-03
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] Multiple myeloma: Topics in basic science applicable to the development of novel therapies2012

    • Author(s)
      Masahiro Abe
    • Organizer
      第74回日本血液学会総会
    • Place of Presentation
      国立京都国際会議場(京都府)
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] SY6-4 Targeting the interplay between myeloma cells and the bone marrow microenvironment2012

    • Author(s)
      M Abe
    • Organizer
      Symposium 6: Multiple myeloma: Topics in basic science applicable to the development of novel therapies.第74回日本血液学会学術集会
    • Place of Presentation
      京都国際会議場(京都府)
    • Year and Date
      2012-10-21
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition2012

    • Author(s)
      Masahiro Abe
    • Organizer
      12th Int'l Meeting on Cancer Induced Bone Disease
    • Place of Presentation
      CITE Centre de Congres (France)
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] An Acidic Milieu Aggravates Myeloma Growth And Drug Resistance But Triggers Anti-myeloma Activity Of Reveromycin A, A Novel Anti-resorptive Agent2011

    • Author(s)
      Abe M
    • Organizer
      11th International Meeting on Cancer Induced Bone Disease
    • Place of Presentation
      Chicago, Illinois, USA
    • Data Source
      KAKENHI-PROJECT-23591390
  • [Presentation] TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma2010

    • Author(s)
      安倍正博
    • Organizer
      10th International Conference Cancer-Induced Bone Disease (Invited Speaker)
    • Place of Presentation
      Sheffield, United Kingdom
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma2010

    • Author(s)
      Masahiro Abe
    • Organizer
      10th International Conference Cancer-Induced Bone Disease
    • Place of Presentation
      Sheffield, UK
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] Facilitation of osteoblast differentiation by ATF-4accumulation through proteasome inhibition2009

    • Author(s)
      安倍正博
    • Organizer
      American Society of Hematology 51st Annual Meeting and Exposition
    • Place of Presentation
      New Orleans Convention Center
    • Year and Date
      2009-11-24
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] Bone marrow microenvironment up-regulates Pim-2 expression in myeloma cells to enhance myeloma cell survival2009

    • Author(s)
      安倍正博
    • Organizer
      The IX International Meeting on Cancer lnduced Bone Diseases
    • Place of Presentation
      Doubletree Hotel, Arlington, Virginia
    • Year and Date
      2009-10-27
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] Bone marrow microenvironment up-regulates Pim-2 expression in myeloma cells to enhance myelorna cell survival2009

    • Author(s)
      安倍正博
    • Organizer
      The IX International Meeting on Cancer Induced Bone Diseases
    • Place of Presentation
      米国Doubletree Hotel Crystal City Arlington, Vrginia
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] Facilitation of osteoblast differentiation by ATF-4accumulation through proteasome inhibition2009

    • Author(s)
      安倍正博
    • Organizer
      Annual Meeting of the American Society of Hematology 51st Annual Meeting and Exposition
    • Place of Presentation
      米国(New Orleans)Morial Convention Center
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] Bone marrow stromal cells up-regulate M-CSF receptor in monocytes to disrupt dendritic cell differentiation while facilitating osteoclastogenesis in myeloma2008

    • Author(s)
      安倍正博
    • Organizer
      ASBMR 2008
    • Place of Presentation
      モントリオール
    • Year and Date
      2008-09-13
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] TACE up-regulation in monocytes by GM-CSF and IL-4 disrupts myeloma cell-induced osteoclastogenesis while inducing dendritic cell differentiation2008

    • Author(s)
      安倍正博
    • Organizer
      International Meeting on Cancer Induced Bone Disease (Invited speaker)
    • Place of Presentation
      Scotland Heriot Watt University
    • Year and Date
      2008-07-02
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] 骨髄腫骨病変に対する新規薬物療法の開発(シンポジウム)2008

    • Author(s)
      安倍正博
    • Organizer
      第17回硬組織再生生物学会総会
    • Place of Presentation
      徳島(徳島文理大学国際会議場)
    • Year and Date
      2008-08-30
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] 多発性骨髄腫骨病変の形成機序の解明と治療法の開発2008

    • Author(s)
      安倍正博
    • Organizer
      第26回日本骨代謝学会学術集会(学術賞受賞講演)
    • Place of Presentation
      大阪(大阪国際会議場)
    • Year and Date
      2008-10-30
    • Data Source
      KAKENHI-PROJECT-20249050
  • [Presentation] Effect of a calcilytic compound in autosomal dominant hypocalcemia model mice.

    • Author(s)
      Bingzi Dong, Itsuro Endo, Takeshi Kondo, Yukiyo Ohnishi, Masahiro Abe, Seiji Fukumoto, Tomoka Hasegawa, Norio Amizuka, Shin-ichi Aizawa, Toshio Matsumoto
    • Organizer
      American Society of Bone and Mineral Research
    • Place of Presentation
      Houston (USA)
    • Year and Date
      2014-09-12 – 2014-09-15
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] 骨髄腫骨病変と腫瘍免疫.シンポジウム5 骨免疫と炎症性疾患.

    • Author(s)
      安倍正博
    • Organizer
      第34回日本炎症・再生医学会
    • Place of Presentation
      国立京都国際会館(京都府)
    • Invited
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combination with the proteasome inhibitor bortezomib.

    • Author(s)
      Keiichiro Watanabe, Masahiro Abe, Hiroshi Mori, Ryota Amachi, Masahiro Hiasa, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto.
    • Organizer
      35th Annual Meeting, the American Society for Bone and Mineral Research, Baltimore
    • Place of Presentation
      Baltimore Convention Center(Baltimore, Maryland, USA)
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] Interleukin-11 is an important factor for mechanical stress-induced osteoblast differentiation and bone formation.

    • Author(s)
      Takeshi Kondo, Bingzi Dong, Takashi Omatsu, Yukiyo Ohnishi, Itsuro Endo, Masahiro Abe, Shinichi Aizawa, Hiroshi Sakaue, Toshio Matsumoto
    • Organizer
      American Society of Bone and Mineral Research
    • Place of Presentation
      Houston (USA)
    • Year and Date
      2014-09-12 – 2014-09-15
    • Data Source
      KAKENHI-PROJECT-25293215
  • [Presentation] Overview of the pathophysiology of MBD and acquired genetic events:Bench work for the targeted therapy to the microenvironment of MBD. Session: Myeloma bone disease.

    • Author(s)
      M Abe.
    • Organizer
      The 14th International Myeloma Workshop.
    • Place of Presentation
      Kyoto International Conference Center( Kyoto, Japan)
    • Invited
    • Data Source
      KAKENHI-PROJECT-25293215
  • []

  • []

  • []

  • 1.  MATSUMOTO Toshio (20157374)
    # of Collaborated Projects: 8 results
    # of Collaborated Products: 35 results
  • 2.  INOUE Daisuke (60314853)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 0 results
  • 3.  ENDO Itsuro (10432759)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 14 results
  • 4.  OZAKI Shuji (90314872)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 0 results
  • 5.  AIHARA Kenichi (70372711)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 6.  NIKI Noboru (80116847)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 7.  KAWATA Yoshiki (70274264)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 8.  SUZUKI Hidenobu (50546710)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 9.  SHIMADA Mitsuo (10216070)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 10.  HARADA Masafumi (20228654)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 11.  IINUMA Gen (60222824)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 12.  KUSUMOTO Masahiko (90252767)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 13.  OHMATSU Hironobu (40415518)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 14.  NAKANO Yasutaka (00362377)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 15.  SAKAI Hiroaki (50362489)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 16.  原田 武志 (10618359)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 17 results
  • 17.  FUJINAKA Yuichi (30432751)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 18.  UENO Junji (60116788)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 19.  OHTSUKA Hideki (30346605)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  TAKAYAMA Tetsuji (10284994)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 21.  ITO Harumi (40026943)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 22.  EGUCHI Kenji (30349336)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 23.  TSUCHIDA Takaaki (80256239)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 24.  TAKAHASHI Masashi (20179526)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 25.  TAKIGUCHI Yuuichi (30272321)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 26.  OHNO Yoshiharu (30324924)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 27.  FUKUMOTO Seiji (30202287)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 28.  AKAIKE Masashi (90271080)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 29.  KIDO Shinsuke (30437652)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 30.  西谷 弘 (50117206)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 31.  井本 逸勢 (30258610)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 32.  梅谷 啓二 (50344396)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 33.  石井 源一郎 (00270869)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 34.  青景 圭樹 (20544753)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 35.  松元 祐司 (00600579)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 36.  三嶋 理晃 (60190625)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 37.  倉橋 清衛 (30567342)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 38.  金井 麻衣 (90836470)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 39.  寺町 順平 (20515986)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 19 results
  • 40.  沢 禎彦 (70271666)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 41.  日浅 雅博 (90511337)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 16 results
  • 42.  KAWAI Shigeto
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 43.  SHIBATA Hironobu
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 44.  TSUJI Daisuke
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 45.  ITAZAWA Tomoko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 46.  TAMAKI Yukihisa
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 47.  NAKAYAMA Yuko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 48.  ISHIZAWA Keisuke
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 49.  NAKASHIMA Tomoki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 50.  三木 浩和
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 51.  藤井 志朗
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 52.  伊藤 孝司
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 53.  小宮山 貴史
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 54.  石澤 有紀
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 55.  尾路 祐介
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 56.  橘 逸勢
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 57.  細井 達矢
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 58.  小川 純人
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 59.  矢可部 満隆
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi